Alison F. Lawton's Insider Trades & SAST Disclosures

Alison F. Lawton's most recent trade in Dianthus Therapeutics Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 22, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Dianthus Therapeutics Inc
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2025 12,500 12,500 - - Stock Option (Right to Buy)
X4 Pharmaceuticals Inc
Alison F. Lawton Director 10 Jun 2024 45,000 96,667 (0%) 0% 0 Common Stock
Dianthus Therapeutics Inc
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 May 2024 11,000 11,000 - - Stock Option (Right to Buy)
Aeglea BioTherapeutics Inc
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2023 1,950,000 1,950,000 - - Stock Option (right to buy)
Aeglea BioTherapeutics Inc
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 43,000 43,000 - - Director Stock Option (right to buy)
X4 Pharmaceuticals Inc
Alison F. Lawton Director 06 Jun 2022 6,667 6,667 (0%) 0% 0 Common Stock
Aeglea BioTherapeutics Inc
Alison F. Lawton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 40,000 40,000 - - Director Stock Option (right to buy)
X4 Pharmaceuticals Inc
Alison F. Lawton Director 02 Jun 2021 6,000 6,000 - - Stock Option (right to buy)
X4 Pharmaceuticals Inc
Alison F. Lawton Director 05 Oct 2020 6,854 6,854 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades